French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Novo Nordisk

Status: Completed

Conditions: Adult Growth Hormone Deficiency; Growth Hormone Disorder

Treatments: Drug: somatropin

Study type: Observational

Funder types: Industry

Identifiers

NCT01580605

GHDA-1755

Details and patient eligibility

About

This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.

Enrollment: 331 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Adult with growth hormone deficiency
• Treated with Norditropin® SimpleXx (somatropin)

Trial design

331 participants in 1 patient group

Users of somatropin

Treatment:

Drug: somatropin